About The Medical Condition KWD2033
Find the definition of the medical term KWD2033. KWD2033 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
KWD2033
| KWD2033 Medical Condition |
|---|
What's The Definition Of The Medical Condition KWD2033?
A partial adrenergic agonist with functional beta 1-receptor specificity and inotropic effect. It is effective in the treatment of acute cardiac failure, postmyocardial infarction low-output syndrome, shock, and reducing orthostatic hypotension in the Shy-Drager syndrome.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- ATPases, Bacterial Proton-Translocating ‐ Membrane-bound proton-translocating ATPases that serve two important…
- Hyperkalemia ‐ Abnormally high potassium concentration in the blood, most often…
- Enhancer Elements (Genetics) ‐ Cis-acting DNA sequences which can increase transcription of…
- Syndrome, Myofascial Pain ‐ Muscular pain in numerous body regions that can be reproduced…
- IgG ‐ The major immunoglobulin in normal…
- Nafcillin, Monosodium Salt, Anhydrous ‐ A semi-synthetic antibiotic related to…
- Disorders, Adjustment ‐ Maladaptive reactions to identifiable psychosocial stressors…
- Software Validations ‐ The act of testing the software for compliance with a…
- Luteoma ‐ A benign ovarian tumor of granulosa or theca-lutein cell origin,…
- Test, Carcinogen ‐ Tests to experimentally measure the tumor-producing/cancer cell-producing…